World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
77182
World Ranking
4432
National Ranking
2415

Overview

Wyndham H. Wilson is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine, with significant contributions in Pathology and Forensic Medicine, Oncology, Genetics, Cancer Research, and Neurology.

Wilson's work covers a range of main topics, including:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CNS Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Viral-associated cancers and disorders
  • CAR-T cell therapy research
  • Lung Cancer Treatments and Mutations

Their recent papers include:

  • "Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL," 2021, Cancer Cell
  • "Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA," 2021, Nature Biotechnology
  • "A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications," 2020, Cancer Cell
  • "Inhibition of Bruton tyrosine kinase in patients with severe COVID-19," 2020, Science Immunology
  • "Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma," 2020, Journal of Clinical Oncology

Frequent co-authors collaborating with Wilson include:

  • Mark Roschewski
  • Louis M. Staudt
  • Christopher Melani
  • Elaine S. Jaffe
  • Stefania Pittaluga

Their research contributions are frequently published in the following venues:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Blood Cancer Discovery
  • Hematological Oncology

Best Publications

  • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

    Ash A. Alizadeh;Michael B. Eisen;R. Eric Davis;Izidore S. Lossos

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

    James N. Kochenderfer;Mark E. Dudley;Steven A. Feldman;Wyndham H. Wilson

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

    James N. Kochenderfer;Wyndham H. Wilson;John E. Janik;Mark E. Dudley

  • Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.

    Andreas Rosenwald;Ash A. Alizadeh;George Widhopf;Richard Simon

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

    Adrian Wiestner;Andreas Rosenwald;Todd S. Barry;George Wright

  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

    Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

    Wyndham H Wilson;Owen A O'Connor;Myron S Czuczman;Ann S LaCasce

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.

    George W. Wright;Da Wei Huang;James D. Phelan;Zana A. Coulibaly

  • Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

    Kieron Dunleavy;Stefania Pittaluga;Myron S. Czuczman;Sandeep S. Dave

  • Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

    Richard L. Piekarz;Rob Robey;Victor Sandor;Susan Bakke

Frequent Co-Authors

Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health
Mark Raffeld
Mark Raffeld National Institutes of Health
Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
Ira Pastan
Ira Pastan Center for Cancer Research
Gerald E. Marti
Gerald E. Marti National Institutes of Health
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse careers far beyond traditional MD programs. For registered nurses aiming to advance quickly, consider the shortest dnp program, which provides a fast track to top nursing leadership roles. Those seeking to enter nursing sooner can look into a 9 month lpn program—an efficient way to begin working in healthcare with a strong foundation.

Another high-demand specialty is mental health. Students interested in this area can enroll in psych np online programs, which blend flexibility with advanced clinical training, preparing graduates for rewarding careers as psychiatric nurse practitioners.

Not all healthcare careers require direct patient care. If you're interested in the business or administrative side, a bachelors in health administration can open pathways in hospital management, public health, and policy leadership.

Online and accelerated healthcare programs offer flexibility, affordability, and a path into many fulfilling professions. Choose your route based on your goals and desired impact in the medical field.

Best Scientists Citing Wyndham H. Wilson

Trending Scientists

Recently Published Articles